Predicting the effects on patients with dilated cardiomyopathy of β-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy

Heterogeneous myocardial distribution of

Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy

✍ Yasuchika Takeishi; Junya Chiba; Shinya Abe; Ichiro Tonooka; Akio Komatani; Hito 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 848 KB

IT has been proposed that iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (123I-BMIPP) is an agent for myocardial fatty acid metabolism in animal models. The aim of the present study was to determine whether alterations in fatty acid uptake and/or utilization in patients with hypertrophi